Detalhe da pesquisa
1.
Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trial.
Pediatr Blood Cancer
; 69(12): e29997, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36129234